The Amphibian Antimicrobial Peptide Temporin B Inhibits In Vitro Herpes Simplex Virus 1 Infection

Antimicrobial Agents and Chemotherapy
M E MarcocciL Nencioni

Abstract

The herpes simplex virus 1 (HSV-1) is widespread in the population, and in most cases its infection is asymptomatic. The currently available anti-HSV-1 drugs are acyclovir and its derivatives, although long-term therapy with these agents can lead to drug resistance. Thus, the discovery of novel antiherpetic compounds deserves additional effort. Naturally occurring antimicrobial peptides (AMPs) represent an interesting class of molecules with potential antiviral properties. To the best of our knowledge, this study is the first demonstration of the in vitro anti-HSV-1 activity of temporin B (TB), a short membrane-active amphibian AMP. In particular, when HSV-1 was preincubated with 20 μg/ml TB, significant antiviral activity was observed (a 5-log reduction of the virus titer). Such an effect was due to the disruption of the viral envelope, as demonstrated by transmission electron microscopy. Moreover, TB partially affected different stages of the HSV-1 life cycle, including the attachment and the entry of the virus into the host cell, as well as the subsequent postinfection phase. Furthermore, its efficacy was confirmed on human epithelial cells, suggesting TB as a novel approach for the prevention and/or treatment of HSV-1 infec...Continue Reading

References

Apr 1, 1992·Clinical Microbiology Reviews·B Bean
Jul 1, 1985·The Journal of General Virology·K S RosenthalC Hodnichak
Dec 1, 1986·Journal of Virology·K A DaherR I Lehrer
Aug 1, 1995·Current Opinion in Structural Biology·S H WhiteM E Selsted
Dec 15, 1996·European Journal of Biochemistry·M SimmacoD Barra
Feb 26, 2000·European Journal of Biochemistry·M L MangoniM Simmaco
May 5, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B YasinE A Wagar
Feb 27, 2001·Journal of Virology·H BultmannC R Brandt
Jan 10, 2002·Journal of Medical Virology·A BelaidK Hani
Jan 25, 2002·Nature·Michael Zasloff
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Sara SinhaBetsy C Herold
Oct 24, 2003·Clinics in Dermatology·Mona Almahroos, Amal K Kurban
Oct 30, 2004·The Journal of Biological Chemistry·Maria Luisa MangoniLuis Rivas
Mar 31, 2006·Cellular and Molecular Life Sciences : CMLS·M L Mangoni
Jul 7, 2007·Memórias do Instituto Oswaldo Cruz·Márcia Cristina Carriel-GomesCláudia Maria Oliveira Simões
Oct 31, 2007·FEBS Letters·Johanna KeyserKarin Moelling
Nov 10, 2007·Reviews in Medical Virology·Russell J DiefenbachAnthony L Cunningham
Apr 25, 2008·Current Protocols in Immunology·W Strober
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Jocelyne Piret, Guy Boivin
Jun 18, 2011·Trends in Biotechnology·Leonard T NguyenHans J Vogel
Jul 8, 2011·International Journal of Antimicrobial Agents·Nicole K Brogden, Kim A Brogden
Dec 17, 2011·Nature Reviews. Drug Discovery·Christopher D FjellGisbert Schneider
Aug 18, 2012·Molecular Neurobiology·Giovanna De ChiaraAnna Teresa Palamara
Oct 18, 2013·BMC Complementary and Alternative Medicine·Manuela DonalisioDavid Lembo
Oct 30, 2013·Journal of Oral Microbiology·Bjørn Grinde
Nov 8, 2013·Frontiers in Microbiology·Kelly C L MulderOctávio L Franco
Mar 19, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Livia CivitelliLetizia Angiolella
Dec 6, 2014·Current Topics in Medicinal Chemistry·Rossella SgarbantiLucia Nencioni
Oct 23, 2015·Viruses·Sylvie SkalickovaRene Kizek
Jan 8, 2016·Experimental Dermatology·Maria Luisa MangoniMichael Zasloff
Nov 3, 2016·Frontiers in Aging Neuroscience·Giovanna De ChiaraDaniela Merlo
Apr 4, 2017·Expert Opinion on Biological Therapy·Josep M SierraMiguel Viñas

❮ Previous
Next ❯

Citations

Dec 6, 2019·Surgical Infections·Stella Maris RomeroSilvana Laura Giudicessi
Apr 28, 2020·Current Topics in Medicinal Chemistry·Bruno CasciaroMaria Luisa Mangoni
Apr 2, 2020·BMC Genetics·Maria Cortázar-ChinarroJacob Höglund
Aug 22, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Antonella Di SottoLucia Nencioni
Mar 25, 2020·International Journal of Peptide Research and Therapeutics·Sathish Kumar MarimuthuLatha Subbiah
May 19, 2019·Cellular and Molecular Life Sciences : CMLS·Liana Costa Pereira Vilas BoasOctávio Luiz Franco
Jul 25, 2019·Current Medicinal Chemistry·Bruno CasciaroMaria Luisa Mangoni
Nov 7, 2019·Nanomaterials·Kateřina ŠkrlováDaniela Plachá
Aug 17, 2020·International Journal of Molecular Sciences·Surajit Bhattacharjya, Suzana K Straus
Nov 11, 2020·Marine Drugs·Natalia P MishchenkoSergey A Fedoreyev
Feb 5, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M De AngelisL Nencioni
Feb 13, 2021·International Journal of Molecular Sciences·Claudio ZippilliRaffaele Saladino
Feb 10, 2021·Infection and Immunity·Nicholas PalmerCésar de la Fuente-Nunez
Apr 13, 2021·Expert Review of Anti-infective Therapy·Masoumeh Sadat Mousavi MalekiHamid Madanchi
May 8, 2021·Journal of Medicinal Chemistry·Stefano TomassiLuciana Marinelli
Sep 21, 2021·Bulletin of Experimental Biology and Medicine·O V IunikhinaM Yu Shchelkanov
Sep 30, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Francesco FiorentinoAntonello Mai
Nov 4, 2021·Microbiology Spectrum·Deyan ChenZhiwei Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
transmission electron microscopy

Software Mentioned

Odyssey
COR Image Studio
GraphPad Prism
LI

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2022 Meta ULC. All rights reserved